Home > Financial Ratios > CONCORD DRUGS

CONCORD DRUGS
EV/Core EBITDA

    Back to All Ratios
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 12.0812.969.267.33

What is the latest EV/Core EBITDA ratio of CONCORD DRUGS ?

The latest EV/Core EBITDA ratio of CONCORD DRUGS is 12.08 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202512.08
Mar202412.96
Mar20239.26
Mar20227.33

How is EV/Core EBITDA of CONCORD DRUGS Trending?

Years EV/Core EBITDA % Change
Mar2025 12.08
-6.79
Mar2024 12.96
39.96
Mar2023 9.26
26.33
Mar2022 7.33 -

Other Financial Ratios of CONCORD DRUGS


Compare EV/Core EBITDA ratio of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹101.5 Cr -3.4% -7.6% 12.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,562.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹244,572.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,871.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹107,770.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,829.0 Cr -0.2% 2.5% -3% Stock Analytics


CONCORD DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

-3.4%

-7.6%

12.9%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses